Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_assertion type Assertion NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_head.
- NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_assertion description "[For the assessment of antiangiogenic gene therapy in the human NB IGR-N835 tumor model, 5 x 10(9) PFU of AdK3-HSA were intravenously injected in tumor-bearing athymic mice presenting either of the following experimental settings: early stage, established, and minimal residual tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_provenance.
- NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_assertion evidence source_evidence_literature NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_provenance.
- NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_assertion SIO_000772 14605672 NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_provenance.
- NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_assertion wasDerivedFrom befree-20140225 NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_provenance.
- NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_assertion wasGeneratedBy ECO_0000203 NP481017.RAPkUqL5OTz7vcL6AFbhr4sYxyWpa_nQ9uWRTlJX4TZ5A130_provenance.